Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seema Nair Parvathy

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Biology Reports|February 8, 2012
Haplotype analysis of the polymorphic 17 YSTR markers in Kerala nontribal populationsSeema Nair Parvathy, Aswathy Geetha, Chippy Jagannath
Exploration of Targeted Anti-Tumor Therapy|December 22, 2025
Therapeutic properties of plant-derived prebiotics in melanomaEmily Kay, Mahnaz Kazi, Jeremy Burton, et al.
The American Journal of Gastroenterology|June 2, 2021
Response to Ianiro et alLaura J Craven, Seema Nair Parvathy, Jeremy P Burton, et al.
Open Forum Infectious Diseases|December 20, 2017
Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated DiseasesLaura J Craven, Seema Nair Parvathy, Justin Tat-Ko, et al.
Critical Reviews in Biotechnology|March 1, 2014
Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenarioSy-Bing Choi, Lee-Ching Lew, Siok-Koon Yeo, et al.
Gut|April 1, 2021
Enhanced donor screening for faecal microbial transplantation during COVID-19Seema Nair Parvathy, John G Lenehan, Ricardo Fernandes, et al.
Frontiers in Medicine|August 28, 2020
Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV InfectionJing Ouyang, Stéphane Isnard, John Lin, et al.
Trends in Molecular Medicine|January 9, 2024
Dissecting mechanisms of fecal microbiota transplantation efficacy in diseaseCatherine M Andary, Kait F Al, John A Chmiel, et al.
The American Journal of Gastroenterology|July 4, 2020
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control TrialLaura Craven, Adam Rahman, Seema Nair Parvathy, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trialDanial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Biology Reports|February 8, 2012
Haplotype analysis of the polymorphic 17 YSTR markers in Kerala nontribal populationsSeema Nair Parvathy, Aswathy Geetha, Chippy Jagannath
Exploration of Targeted Anti-Tumor Therapy|December 22, 2025
Therapeutic properties of plant-derived prebiotics in melanomaEmily Kay, Mahnaz Kazi, Jeremy Burton, et al.
The American Journal of Gastroenterology|June 2, 2021
Response to Ianiro et alLaura J Craven, Seema Nair Parvathy, Jeremy P Burton, et al.
Open Forum Infectious Diseases|December 20, 2017
Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated DiseasesLaura J Craven, Seema Nair Parvathy, Justin Tat-Ko, et al.
Critical Reviews in Biotechnology|March 1, 2014
Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenarioSy-Bing Choi, Lee-Ching Lew, Siok-Koon Yeo, et al.
Gut|April 1, 2021
Enhanced donor screening for faecal microbial transplantation during COVID-19Seema Nair Parvathy, John G Lenehan, Ricardo Fernandes, et al.
Frontiers in Medicine|August 28, 2020
Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV InfectionJing Ouyang, Stéphane Isnard, John Lin, et al.
Trends in Molecular Medicine|January 9, 2024
Dissecting mechanisms of fecal microbiota transplantation efficacy in diseaseCatherine M Andary, Kait F Al, John A Chmiel, et al.
The American Journal of Gastroenterology|July 4, 2020
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control TrialLaura Craven, Adam Rahman, Seema Nair Parvathy, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trialDanial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, et al.
Pageof 2